Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety

NCT00263692 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

401

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Acellular Pertussis
Tetanus

Interventions

BIOLOGICAL: Prophylaxis: Diphtheria, tetanus, pertussis, poliovirus type 1, type 2 and type 3

Sponsor

GlaxoSmithKline